NEPHROS INC·4

Dec 18, 5:13 PM ET

Lask Alisa 4

4 · NEPHROS INC · Filed Dec 18, 2019

Insider Transaction Report

Form 4
Period: 2019-12-16
Lask Alisa
Director
Transactions
  • Award

    Common Stock

    2019-12-16+3,2273,477 total
  • Award

    Stock Option (right to buy)

    2019-12-16+5,5685,568 total
    Exercise: $8.57Exp: 2029-12-16Common Stock (5,568 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $5.22Exp: 2029-02-08Common Stock (9,617 underlying)
    9,617
Footnotes (3)
  • [F1]On December 16, 2019, the Company granted 3,227 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Ms. Lask in respect of her services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The Restricted Stock vests 6 months following the grant date.
  • [F2]The option vests as to 3,206 shares on each of 2/8/19 and 2/8/20 and as to 3,205 shares on 2/8/21.
  • [F3]On December 16, 2019, the Company granted an option to purchase 5,568 shares of common stock of the Company (the "Option") in respect of the service by Ms. Lask as a member of the Board of Directors of the Company. The Option was granted under the 2015 Plan. The Option vests as to 1,856 shares on each of 12/16/19, 12/16/20 and 12/16/21.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT